75 related articles for article (PubMed ID: 33558123)
1. Increased expression of thyroid hormone receptor alpha and estrogen receptor alpha in breast cancer associated with thyroid cancer.
Kim YA; Kim YA; Cho SW; Song YS; Min HS; Park IA; Park DJ; Hwang KT; Park YJ
Eur J Surg Oncol; 2021 Jun; 47(6):1316-1323. PubMed ID: 33558123
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis.
Tan W; Li Q; Chen K; Su F; Song E; Gong C
Oncotarget; 2016 Mar; 7(9):10373-85. PubMed ID: 26863572
[TBL] [Abstract][Full Text] [Related]
3. SMAD3, Cell proliferation and lymph nodes metastasis in breast cancer hormone-dependent.
Oueslati M; Sassi N; Bettaieb I; Gamoudi A; Rahal K; Oueslati R
Tunis Med; 2023 Feb; 101(2):273-279. PubMed ID: 37682272
[TBL] [Abstract][Full Text] [Related]
4. Survival Outcomes in Thyroid Cancer Patients with Co-Occurring Breast Cancer: Evidence of Mortality Risk Attenuation.
Baumgarten MW; Goemann IM; Scheffel RS; Maia AL
Clin Breast Cancer; 2024 Apr; ():. PubMed ID: 38670860
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer-associated fibroblasts.
Cirillo F; Pellegrino M; Talia M; Perrotta ID; Rigiracciolo DC; Spinelli A; Scordamaglia D; Muglia L; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Maggiolini M; Lappano R
Clin Transl Med; 2021 Nov; 11(11):e516. PubMed ID: 34841688
[TBL] [Abstract][Full Text] [Related]
6. The Significance of Thyroid Hormone Receptors in Breast Cancer: A Hypothesis-Generating Narrative Review.
Quan T; Cockburn J; Dhesy-Thind S; Bane A; Leong H; Geleff C; Devion C; Ajel N; Jerzak KJ
Curr Oncol; 2024 Apr; 31(5):2364-2375. PubMed ID: 38785457
[TBL] [Abstract][Full Text] [Related]
7. Investigation of common genetic risk factors between thyroid traits and breast cancer.
Lucotte EA; Asgari Y; Sugier PE; Karimi M; Domenighetti C; Lesueur F; Boland-Augé A; Ostroumova E; de Vathaire F; Zidane M; Guénel P; Deleuze JF; Boutron-Ruault MC; Severi G; Liquet B; Truong T
Hum Mol Genet; 2023 Dec; 33(1):38-47. PubMed ID: 37740403
[TBL] [Abstract][Full Text] [Related]
8. Granzyme h serum levels variations with both reproductive hormone receptors, and related hormone receptors in breast cancer patients.
Tahbaz-Lahafi B; Akbari ME; Amir-Rassouli H; Rahimipour A; Azargashb E; Nafissi N; Jahani F
Iran J Cancer Prev; 2014; 7(1):48-52. PubMed ID: 25250148
[TBL] [Abstract][Full Text] [Related]
9. Expression of Estrogen and Progesterone Receptors in Papillary Thyroid Carcinoma in Korea.
Ahn HY; Song RY; Ahn HS; Kim HS
Cancer Res Treat; 2021 Oct; 53(4):1204-1212. PubMed ID: 33592140
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Smart Speaker-Based Metamemory Training in Older Adults: Case-Control Cohort Study.
Kim J; Shin E; Han K; Park S; Youn JH; Jin G; Lee JY
J Med Internet Res; 2021 Feb; 23(2):e20177. PubMed ID: 33591276
[TBL] [Abstract][Full Text] [Related]
11. Co-occurrence of thyroid and breast cancer is associated with an increased oncogenic SNP burden.
Bakos B; Kiss A; Árvai K; Szili B; Deák-Kocsis B; Tobiás B; Putz Z; Ármós R; Balla B; Kósa J; Dank M; Valkusz Z; Takács I; Tabák Á; Lakatos P
BMC Cancer; 2021 Jun; 21(1):706. PubMed ID: 34130653
[TBL] [Abstract][Full Text] [Related]
12. Association between breast cancer and thyroid cancer risk: a two-sample Mendelian randomization study.
Tan H; Wang S; Huang F; Tong Z
Front Endocrinol (Lausanne); 2023; 14():1138149. PubMed ID: 37288296
[TBL] [Abstract][Full Text] [Related]
13. 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.
Bible KC; Kebebew E; Brierley J; Brito JP; Cabanillas ME; Clark TJ; Di Cristofano A; Foote R; Giordano T; Kasperbauer J; Newbold K; Nikiforov YE; Randolph G; Rosenthal MS; Sawka AM; Shah M; Shaha A; Smallridge R; Wong-Clark CK
Thyroid; 2021 Mar; 31(3):337-386. PubMed ID: 33728999
[No Abstract] [Full Text] [Related]
14. Analyses of the Relation between BPPV and Thyroid Diseases: A Nested Case-Control Study.
Choi HG; Song YS; Wee JH; Min C; Yoo DM; Kim SY
Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33671325
[TBL] [Abstract][Full Text] [Related]
15. Common tumor-suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells.
Bolf EL; Gillis NE; Davidson CD; Cozzens LM; Kogut S; Tomczak JA; Frietze S; Carr FE
Mol Carcinog; 2021 Dec; 60(12):874-885. PubMed ID: 34534367
[TBL] [Abstract][Full Text] [Related]
16. The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice.
Piek MW; de Boer JP; van Duijnhoven F; van der Wal JE; Vriens M; van Leeuwaarde RS; van der Ploeg IMC
BMC Cancer; 2022 Sep; 22(1):1018. PubMed ID: 36163009
[TBL] [Abstract][Full Text] [Related]
17. Assessment of surveillance versus etiologic factors in the reciprocal association between papillary thyroid cancer and breast cancer.
Advani PG; Morton LM; Kitahara CM; Berrington de Gonzalez A; Ramin C; Haymart MR; Curtis RE; Schonfeld SJ
Cancer Epidemiol; 2021 Oct; 74():101985. PubMed ID: 34280845
[TBL] [Abstract][Full Text] [Related]
18. Appraising the Effect of Potential Risk Factors on Thyroid Cancer: A Mendelian Randomization Study.
Huang L; Feng X; Yang W; Li X; Zhang K; Feng S; Wang F; Yang X
J Clin Endocrinol Metab; 2022 Jun; 107(7):e2783-e2791. PubMed ID: 35366326
[TBL] [Abstract][Full Text] [Related]
19. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.
Goldgar DE; Easton DF; Cannon-Albright LA; Skolnick MH
J Natl Cancer Inst; 1994 Nov; 86(21):1600-8. PubMed ID: 7932824
[TBL] [Abstract][Full Text] [Related]
20. Hormonal Crosstalk Between Thyroid and Breast Cancer.
Halada S; Casado-Medrano V; Baran JA; Lee J; Chinmay P; Bauer AJ; Franco AT
Endocrinology; 2022 Jul; 163(7):. PubMed ID: 35587175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
